Full-Time

Business Development Relationship Associate

Posted on 7/28/2025

GMO

GMO

501-1,000 employees

Asset management with long-term, valuation-based investing

Compensation Overview

$65k - $80k/yr

No H1B Sponsorship

Boston, MA, USA

Hybrid

Category
Business & Strategy (1)
Required Skills
Salesforce
Excel/Numbers/Sheets
Requirements
  • 2-3 years of experience in the investment management business
  • Bachelor’s Degree (or equivalent)
  • Strong ability to create, operate, maintain and organize databases
  • Proficient in MS Excel and other Microsoft applications
  • Excellent written and verbal communication capabilities
  • Strong organizational skills and attention to detail
  • Strong analytical skills
  • Demonstrated understanding of investment strategies and markets, including fixed income, equity and alternatives
  • Some basic knowledge of the North American asset management industry
  • Previous experience working with SalesForce or another CRM preferred
  • Will be required to pass Series 63, 7 and 3 within one year
Responsibilities
  • In concept, the BD Associate role is flexible leverage for the BD Managers they support with the goal of cultivating relationships and ultimately bringing in new clients/mandates.
  • The job’s day-to-day is a mix of research, data organization, administrative tasks, and direct external engagements (email, calls, virtual meetings, and in-person meetings).
  • Maintaining current prospect list in CRM and outside of CRM including tags which identify areas in which the prospect is interested; increasing prospect list using databases such as Broadridge, Dakota, Market Lens; building distribution lists for virtual events, email campaigns, and other distributions
  • Writing template emails and sending semi-customized emails to distribution list; personalizing emails to prospects, email responses and getting meetings/calls scheduled & prospects to attend events
  • Own meeting logistics including calendar invitations, logging to Salesforce, prep notes, presentation materials
  • Preparation of prep notes including prospect information, research on prospects, competitor information, and custom competitive analysis in Excel
  • Assist in organizing GMO specific investor and marketing events in North America
  • Documenting and maintaining meeting notes; translating meeting to prospect list tag; conducting meeting follow-ups from Seismic, website, etc.
  • Develop a thorough understanding of GMO’s policies and procedures to facilitate efficient delivery of information and services to GMO’s prospect community
  • Work with GMO’s team of investment professionals independently and at the direction of the team leader to ensure prospects experience the highest level of satisfaction
  • Collaborate with Graphics, Performance Analytics, Operations, Investment teams, RFP, Tax, Legal and Compliance across GMO
  • With time, understand and articulate GMO’s investment strategies, philosophy and process
  • Identify prospective clients of competitors that should be included in our business development plans

GMO provides investment management for institutions, financial intermediaries, and families worldwide, across asset classes. It operates through specialized investment teams guided by a long-term, valuation-based philosophy to identify opportunities and tailor solutions. The firm emphasizes an open culture of debate, contrarian opportunities, and bespoke client service to differentiate itself. Its goal is to help clients meet their financial objectives by delivering prudent, risk-adjusted results through tailored investment strategies.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Boston, Massachusetts

Founded

1977

Simplify Jobs

Simplify's Take

What believers are saying

  • GMO Venture Partners led DPDzero's $7M Series A, expanding AI fintech investments.
  • QLTY ETF launched with Goldman Sachs Accelerator enters active ETF market.
  • Net zero targets under 2021 NZAM commitment drive climate-resilient portfolios by 2050.

What critics are saying

  • Nuveen named best large fund group in 2026 Lipper Awards, diverting GMO's institutional flows.
  • AQR wins 9 Lipper Awards, eroding GMO's prestige beyond single emerging debt win.
  • Persistent US rate hikes spike emerging sovereign defaults, devastating GMO debt fund positions.

What makes GMO unique

  • GMO Emerging Country Debt Fund won 2026 LSEG Lipper Award for top-decile performance since 1994.
  • Deep value strategy targets cheapest 20% equities since May 2023 at 2nd percentile valuations.
  • Nebo platform automates needs-based optimization for RIAs, finalist in Industry Disruptor Awards.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Company News

StreetInsider
Mar 26th, 2026
Tazapay raises $36M Series B to scale cross-border payment infrastructure across Asia, LATAM and Middle East

Tazapay, a payment infrastructure provider for emerging markets, has raised $36 million in total Series B funding, with Circle Ventures leading an extension round. New investors CMT Digital and Coinbase Ventures joined existing backers including Peak XV Partners, GMO Venture Partners and Ripple. The Singapore-based company uses digital settlement technology to power cross-border payments across Asia, Latin America and the Middle East. Tazapay holds licences in Singapore, Canada, Australia and the US, with applications pending in the UAE, EU and Hong Kong. The company has doubled revenues for three consecutive years and now serves over 1,000 enterprises and fintechs across 30 countries. Funding will support regulatory expansion into new jurisdictions and markets, with a focus on infrastructure for AI-driven autonomous payments.

The AI Journal Ltd
Mar 12th, 2026
GMO Emerging Country Debt Fund Wins 2026 LSEG Lipper Fund Award; Access Expanded for U.S. Advisors

GMO Emerging Country Debt Fund wins 2026 LSEG Lipper Fund Award; access expanded for U.S. Advisors. BOSTON-(BUSINESS WIRE)-GMO, a global investment manager known for its long-term, valuation-oriented strategies, today announced that the GMO Emerging Country Debt Fund received a 2026 LSEG Lipper Fund Award in the Emerging Markets Hard Currency Debt category. The award recognizes the fund's three-year performance, which reflects the team's history of delivering top-decile peer performance going back to the fund's 1994 inception. "We are grateful for this recognition of our deeply experienced team, as well as our genuinely differentiated approach to the asset class, which remains as relevant today as when it was founded over 30 years ago," said Tina Vandersteel, lead portfolio manager for GMO's emerging debt strategies. "This award is a reflection of our constant effort to turn out singles and doubles through arbitrage-focused security selection while keeping an eye out for triples and home runs that can come around sovereign distress and work out." The GMO Emerging Country Debt Fund seeks to add value primarily through security selection within a country's sovereign, quasi sovereign corporate, and occasional opportunistic local debt markets exposures, and secondarily through active country positioning. The fund is benchmarked to the J.P. Morgan EMBI Global Diversified Index. Over its history, the strategy has generated attractive long-term excess returns versus the benchmark while offering diversification benefits within multi-asset portfolios. GMO has recently expanded access to its Emerging Country Debt capabilities with the launch of the GMO Emerging Country Debt Shares Fund (GMAJX), which is designed specifically for U.S. intermediary and wealth platforms and provides streamlined operational access to the underlying Emerging Country Debt Fund. The new vehicle allows wealth platforms to offer GMO's ECD strategy to their advisor and RIA clients. "The combination of compelling long-term beta, strong alpha potential, and diversification benefits makes emerging market debt a powerful complement to traditional fixed income allocations. We believe many investors can benefit from a dedicated, actively managed allocation to this asset class, and we are pleased that a wider range of advisors and their clients can now access this approach through our new U.S. vehicle," said Alex Bark, Head of Global Client Relations at GMO. Global investment manager GMO, established in 1977, brings together focused expertise within its investment teams, industry-leading research, and client solutions and service to advance clients' goals. Privately owned and renowned for conviction in a valuation-based, long-term investment philosophy, GMO serves sophisticated institutions, financial intermediaries, and families, and managed $78.2 billion as of December 31, 2025. The firm is headquartered in Boston, with offices in London, Sydney, Amsterdam, Singapore, and Tokyo (representative office). About the LSEG Lipper Fund Awards The LSEG Lipper Fund Awards, granted annually, highlight funds and fund companies that have excelled in delivering consistently strong risk-adjusted performance relative to their peers. The LSEG Lipper Fund Awards are based on the Lipper Leader for Consistent Return rating, which is a risk-adjusted performance measure calculated over 36, 60 and 120 months. The fund with the highest Lipper Leader for Consistent Return (Effective Return) value in each eligible classification wins the LSEG Lipper Fund Award. For more information, see lipperfundawards.com. Although LSEG makes reasonable efforts to ensure the accuracy and reliability of the data contained herein, the accuracy is not guaranteed by LSEG Lipper. Risks associated with investing in the Fund may include: (1) Credit Risk: the risk that the issuer or guarantor of a fixed income investment or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner; (2) Market Risk - Fixed Income Investments: the market price of a fixed income investment can decline due to a number of market-related factors, including rising interest rates and widening credit spreads or decreased liquidity stemming from the market's uncertainty about the value of a fixed income investment (or class of fixed income investments); and (3) Illiquidity Risk: Low trading volume, lack of a market maker, large position size, or legal restrictions may limit or prevent the Fund from selling particular securities or closing derivative positions at desirable prices. For a more complete discussion of these and other risks, please consult the Fund's Prospectus. An investor should carefully consider the fund's investment objectives, risks, charges and expenses before investing. This and other important information can be found in the fund's prospectus. To obtain a prospectus please visit www.gmo.com. Read the prospectus carefully before investing. The J.P. Morgan EMBI (Emerging Markets Bond) Index Global Diversified is an independently maintained and widely published, uniquely weighted, U.S. dollar-denominated emerging markets sovereign index comprised of Brady bonds, Eurobonds, traded loans, and market debt instruments issued by sovereign and quasi-sovereign entities. Alpha is a measure of risk-adjusted return. Beta is a measure of a portfolio's sensitivity to the market. The GMO Trust funds are distributed in the United States by Funds Distributor LLC. GMO and Funds Distributor LLC are not affiliated. Media: Steve Schaefer Hewes Communications, Inc. 212-207-9456 [email protected]

Business Standard
Aug 6th, 2025
DPDzero raises $7 mn Series A to scale AI-powered debt collections

Debt collections platform DPDzero secures $7 mn Series A funding led by GMO Venture Partners, SMBC Asia Rising Fund, and Blume Ventures to expand AI and field collection network

TechCrunch
Mar 11th, 2025
Zolve, a neobank for global citizens moving to the US, raises $51M and secures $200M debt | TechCrunch

Zolve, a neobanking startup targeting global citizens seeking credit, has raised $251 million in a new round to expand into Canada and launch loans.

Yahoo Finance
Aug 26th, 2024
Why Investors Should Load Up On Cheap, 'Left Behind' Stocks As The Market Trades Near Record Highs, Jeremy Grantham'S Gmo Says

Jeremy Grantham Matthew Lloyd/Getty Images for ReSource 2012Investors can best prepare against an eventual market slowdown by buying cheap, unloved stocks, GMO says.The investment firm finds the extreme discounts of deep value stocks attractive.Once bullish sentiment starts to unwind, these valuations should correct, GMO wrote.It's time to embrace the market's cheapest stocks, with the value sector poised to eventually roar back, GMO wrote in a new research note.The investment firm, led by legendary investor Jeremy Grantham, outlined a high conviction in "deep value" equities — or stocks that are cheap relative to their genuine fundamental worth.Based on this criteria, the investment firm began targeting the cheapest 20% of stocks in May 2023, steering clear of "deceptively cheap" value traps."In a world where many stocks are being driven ever higher by positive sentiment and investor optimism, many of the ones that have been most unloved and left behind are trading at extraordinary discounts," the firm wrote.Over the past year, US investment has skewed heavily toward large-cap tech names, helping benchmark indexes notch a series of all-time highs.Against this backdrop, deep value stocks have become extremely cheap — not only against the broader market but also in comparison to history."Outside of the US all value is cheap, but deep value is in the 2nd percentile of its history," the note said. "Within the US, deep value is similarly sitting at the 10th percentile of its history, while the rest of value should largely be ignorable at current valuations."According to GMO, that makes deep value well-positioned to deliver strong returns once investor sentiment toward mega-caps starts to unwind. Earlier this year, GMO projected a 1% decline in US large-caps in the next seven years, predicting that deep value stocks will achieve 7.6% gains."The S&P 500 is tech and growth heavy, so an investment in international value is the perfect complement from more than just a regional perspective," GMO wrote.Read the original article on Business Insider

INACTIVE